- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04656977
Providing Psychological and Emotional Support After Perinatal Loss: A Virtual Reality-Based Intervention (DIANE)
December 3, 2020 updated by: Giulia Corno, Universite du Quebec en Outaouais
Évaluer l'efficacité d'Une Intervention en réalité Virtuelle Sur le Bien-être Des Femmes Ayant vécu un décès périnatal : un Essai contrôlé randomisé
The loss of an infant during the perinatal period has been recognized as a complex and potentially traumatic life event and can have a significant impact on women's mental health.
However, often times, psychological aftercare is typically not offered, and manualized interventions are rarely used in clinical care practice and have seldom been evaluated.
In recent years, a growing number of studies have demonstrated the efficacy of virtual reality (VR) interventions to facilitate the expression and coping with emotions linked to a traumatic event.
The objective of the proposed paper is to present the protocol of a randomized control trial aimed to assess a novel VR-based intervention for mothers who experienced a perinatal loss.
The investigators hypothesize that the VR-based intervention group will show significantly reduced symptoms related to grief, postnatal depression and general psychopathology after treatment relative to a treatment-as-usual (TAU) group.
With the present study the investigators propose to answer to the unquestionable need for interventions addressed to ameliorate the emotional effects in women who experienced perinatal loss, by exploiting also the therapeutic opportunities offered by a new technology as VR.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Giulia Corno, Ph.D.
- Phone Number: 2531 819-595-3900
- Email: giulia.corno@uqo.ca
Study Locations
-
-
Quebec
-
Gatineau, Quebec, Canada, J8T3X7
- Recruiting
- Universite du Quebec en Outaouais
-
Contact:
- Giulia Corno, PhD
- Phone Number: 8192136724
- Email: giulia.corno@uqo.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Mothers who had recently experienced a perinatal death, including: having lost a child during pregnancy because of miscarriage (i.e., embryo or fetus death prior the 28th week of gestation); termination due to medical indications; stillbirth (i.e., fetus death after 28 completed weeks of gestation); or neonatal death (i.e., infant death within the first 7 days of life).
- Women who have experienced perinatal death while pregnant within no more than 1 year before the enrollment will be invited to participate to the study.
Exclusion Criteria:
- Significant vision impairments despite wearing corrective glasses or lenses.
- Presence of a severe and disabling diagnosed mental disorder which requires immediate treatment.
- Being under psychological treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: VR+TAU
Participants will participate first to a VR-based intervention and then to the TAU condition.
The TAU condition is a homogenous standard program proposed by the Centre d'études et de recherché en intervention familiale (CERIF) at Université du Québec en Outaouais (UQO) based on group counseling offered to women and men who experienced a perinatal loss.
|
The proposed intervention will consist in three weekly sessions of 2h focused, respectively, on: (1) gathering information about the loss and psychoeducation about perinatal grief, and introduction to the virtual environment; (2) through the use of the virtual environment, women will be assisted in the elaboration and acceptation of loss; (3) recreate, using the features of the virtual environment (i.e., a series of different virtual landscapes and symbolic elements personalized to each participant as personal pictures, sounds or videos) a new and positive metaphor representing the woman's future life.
Other Names:
The TAU condition is a homogenous standard program proposed by the CERIF at UQO based on group counseling offered to women and men who experienced a perinatal loss.
Other Names:
|
ACTIVE_COMPARATOR: TAU+VR
Participants will be invited first to participate to the TAU condition and then to the VR-based intervention.
|
The proposed intervention will consist in three weekly sessions of 2h focused, respectively, on: (1) gathering information about the loss and psychoeducation about perinatal grief, and introduction to the virtual environment; (2) through the use of the virtual environment, women will be assisted in the elaboration and acceptation of loss; (3) recreate, using the features of the virtual environment (i.e., a series of different virtual landscapes and symbolic elements personalized to each participant as personal pictures, sounds or videos) a new and positive metaphor representing the woman's future life.
Other Names:
The TAU condition is a homogenous standard program proposed by the CERIF at UQO based on group counseling offered to women and men who experienced a perinatal loss.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Perinatal Grief Scale (change)
Time Frame: Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
Inventory of Complicated Grief (change)
Time Frame: Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
Beck Depression Inventory-II (change)
Time Frame: Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
Edinburgh Postnatal Depression Scale (change)
Time Frame: Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
State and Trait Anxiety Inventory form Y (change)
Time Frame: Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
Positive and Negative Affect Scale (change)
Time Frame: Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
Clinical Global Impression rated by the therapist (change)
Time Frame: Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
Day 1 (pre-assessment), up to 3 weeks from day 1, up to 6 weeks from day 1
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Client Satisfaction Questionnaire
Time Frame: Up to 3 weeks from day 1, up to 6 weeks from day 1
|
Up to 3 weeks from day 1, up to 6 weeks from day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 16, 2020
Primary Completion (ANTICIPATED)
June 1, 2022
Study Completion (ANTICIPATED)
October 1, 2022
Study Registration Dates
First Submitted
November 10, 2020
First Submitted That Met QC Criteria
December 3, 2020
First Posted (ACTUAL)
December 7, 2020
Study Record Updates
Last Update Posted (ACTUAL)
December 7, 2020
Last Update Submitted That Met QC Criteria
December 3, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2020-867
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Grief
-
Universitat Jaume ICompleted
-
Memorial Sloan Kettering Cancer CenterCalvary Hospital, Bronx, NYCompleted
-
Ludwig-Maximilians - University of MunichCompleted
-
University of SaskatchewanSaskatchewan Health Research FoundationCompleted
-
NYU Langone HealthTerminated
-
Ersta Sköndal University CollegeCompleted
-
University of TromsoUnknownComplicated Grief
-
Mayo ClinicRecruiting
-
Carlos III Health InstituteHealth Department of the Basque GovernmentCompleted
Clinical Trials on VR
-
National Institute of General Medical Sciences...Completed
-
University of Maryland, BaltimoreNot yet recruitingPain | Virtual Reality | Temporomandibular Disorder | PlaceboUnited States
-
Cornell UniversityRecruitingPain ThresholdUnited States
-
Catholic University of the Sacred HeartFondazione PoliambulanzaRecruiting
-
Indiana UniversityAmerican Heart AssociationCompletedHeart Failure | Cognitive DysfunctionUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
National Institutes of Health Clinical Center (CC)Not yet recruitingNeoplasm | CaregiversUnited States
-
Medical University of LodzNational Center for Research and Development, Poland; Senopi AGRecruiting
-
Azienda Ospedaliero-Universitaria di ParmaMinistry of Health, ItalyRecruitingStroke | Hemiplegia | HemiparesisItaly
-
Children's Hospital Medical Center, CincinnatiCompleted